CSIR Collaborates with Intel And IIIT-Hyderabad To Combat COVID-19

CSIR Collaborates with Intel And IIIT-Hyderabad To Combat COVID-19

  • Research Stash
  • News
  • 1.7K

Faster testing and predicting rapidly the patients at risk is crucial to mitigate SARS-CoV-2 transmission. The Council of Scientific and Industrial Research (CSIR) is working with Intel India and International Institute of Information Technology (IIIT), Hyderabad, to help achieve faster and less expensive COVID-19 testing and coronavirus genome sequencing to understand the epidemiology and Artificial Intelligence (AI)-based risk stratification for patients with co-morbidities.

As part of the initiative, Intel India is developing an end-to-end system that consists of multiple applications, testing devices, data collection/aggregation gateways, a data exchange software development kit (SDK) and an AI model-hub platform. CSIR constituent labs such as CSIR-IGIB, CSIR-CCMB, CSIR-IMTECH, CSIR-IIP, CSIR-CLRI, and others will work with various hospitals and diagnostic chains in carrying out comprehensive diagnostics. IIIT-Hyderabad will develop risk stratification algorithms that can help in drug and vaccine discovery for long-term preparedness to combat the epidemic.

“Multi-disciplinary partnerships are key to tackling the challenge of COVID-19 and CSIR is happy to collaborate with IIIT-Hyderabad and Intel India which bring in complementary strengths in genomics, big data and AI”, observed Dr. Shekhar C. Mande, DG-CSIR.

“Intel India is committed to working with CSIR and IIIT-Hyderabad to rapidly develop and deploy solutions in the fight against COVID-19. Intel creates technologies that enrich lives and this initiative exemplifies our focus on deploying advanced technology to find effective and scalable solutions for urgent local needs. Technology has become cheaper, more accessible and far more efficient since SARS-CoV-1 hit us and remains crucial in this fight against SARS-CoV-2 as it enables diagnostics, drug and vaccine discovery with higher predictability, speed, and accuracy,” said Nivruti Rai, Country Head, Intel India and Vice President, Data Platforms Group, Intel Corporation.

PJ Narayanan, Director, IIIT-Hyderabad, noted, “It is exciting for IIIT-Hyderabad to work with the country’s top scientists from several CSIR laboratories and an industry leader like Intel on developing solutions for better sequencing of COVID-19 and other problems. We are looking forward to contributing our bit to this activity through our expertise in algorithms, science, and AI”.

Umashankar Mishra

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

Rate

“Intel India is committed to working with CSIR and IIIT-Hyderabad to rapidly develop and deploy solutions in the fight against COVID-19. Intel creates technologies that enrich lives and this initiative exemplifies our focus on deploying advanced technology to find effective and scalable solutions for urgent local needs. Technology has become cheaper, more accessible and far more efficient since SARS-CoV-1 hit us and remains crucial in this fight against SARS-CoV-2 as it enables diagnostics, drug and vaccine discovery with higher predictability, speed, and accuracy,” said Nivruti Rai, Country Head, Intel India and Vice President, Data Platforms Group, Intel Corporation.

PJ Narayanan, Director, IIIT-Hyderabad, noted, “It is exciting for IIIT-Hyderabad to work with the country’s top scientists from several CSIR laboratories and an industry leader like Intel on developing solutions for better sequencing of COVID-19 and other problems. We are looking forward to contributing our bit to this activity through our expertise in algorithms, science, and AI”.

Umashankar Mishra

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

" }
Dr Rajanish Giri in his lab at IIT-Mandi

Scientists Find Antimalarial Drug May Be Repurposed to Treat Zika

In their search for a possible treatment for Zika virus infection, a team of Indian researchers has identified a viral protein that can be targeted by an already available antimalarial drug, hydroxychloroquine

  • News
  • 2.6K
Read more
Popular Rice Variety Gets Extra Gene Power to Fight Bacterial Attacks

Popular Rice Variety Gets Extra Gene Power to Fight Bacterial Attacks

Researchers at the Hyderabad-based Indian Institute of Rice Research have developed a new variety of the popular Improved Samba Mahsuri (ISM) rice that can resist bacterial blight disease.

  • News
  • 2.3K
Read more

Step inside the mind of the young Stephen Hawking as his PhD thesis goes online for the first time

Stephen Hawking’s Ph.D. thesis, ‘Properties of expanding universes’, has been made freely available to anyone, anywhere in the world, after being made accessible via the University of Cambridge’s Open Access repository, Apollo.

  • News
  • 2.7K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit